Skip to Main Content

Paper Details

MiR-100 is a predictor of endocrine responsiveness and prognosis in patients with operable luminal breast cancer.
ESMO Open
10
2020
Author NameAffiliation
Enzo MedicoUniversity of Turin, Candiolo Cancer Institute, FPO-IRCCS
  • 1 - 1

Datasets

Release 1.2